Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Pancreatic ductal adenocarcinoma (PDAC) cells display varying degrees of reliance on oncogenic KRAS. Here the authors show that KRAS-resistant PDAC cells maintain nucleotides synthesis through a KRAS-independent upregulation of the non-oxidative pentose phosphate pathway gene RPIA and that targeting...
Main Authors: | Naiara Santana-Codina, Anjali A. Roeth, Yi Zhang, Annan Yang, Oksana Mashadova, John M. Asara, Xiaoxu Wang, Roderick T. Bronson, Costas A. Lyssiotis, Haoqiang Ying, Alec C. Kimmelman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-07472-8 |
Similar Items
-
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.
by: Meredith A Collins, et al.
Published: (2012-01-01) -
Kras as a key oncogene and therapeutic target in pancreatic cancer.
by: Meredith A Collins, et al.
Published: (2014-01-01) -
Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
by: Wiesława Niklińska, et al.
Published: (2009-05-01) -
Oncogenic KRAS Expression and Signaling
by: Lampson, Benjamin Logan
Published: (2012) -
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
by: Adrian Vallejo, et al.
Published: (2017-02-01)